Parafend Plus Oral Suspension

Kraj: Irlandia

Język: angielski

Źródło: HPRA (Health Products Regulatory Authority)

Składnik aktywny:

Oxfendazole; Closantel

Dostępny od:

Norbrook Laboratories (Ireland) Limited

Kod ATC:

QP52AC52

INN (International Nazwa):

Oxfendazole; Closantel

Dawkowanie:

25/50 milligram(s)/millilitre

Forma farmaceutyczna:

Oral suspension

Typ recepty:

POM: Prescription Only Medicine as defined in relevant national legislation

Dziedzina terapeutyczna:

oxfendazole, combinations

Status autoryzacji:

Authorised

Data autoryzacji:

2003-06-30

Charakterystyka produktu

Health Products Regulatory Authority
27 February 2019
CRN008TS7
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Parafend Plus Oral Suspension
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
​
ACTIVE SUBSTANCES
​
​
​
Oxfendazole
2.5% w/v​
[25 mg/ml]​
​
Closantel
5.0% w/v​
[50 mg/ml]​
​
For a full list of excipients, see section 6.1
​
​
3 PHARMACEUTICAL FORM
Oral suspension.
An off white suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Sheep.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of mixed infections of mature and developing
immature gastrointestinal roundworms, lungworms,
tapeworms and fluke or sheep nasal fly in sheep and lambs. It is
ovicidal against nematode eggs and delays egg laying in
trematodes (fluke).
The product is recommended for the treatment of mixed infections
including:
GASTROINTESTINAL ROUNDWORMS:
_Ostertagia_ spp (adult, arrested and inhibited larvae)
_Haemonchuscontortus _(adult, arrested and inhibited larvae)
_Nematodirus_ spp (including _N.battus_) (adult and immature)
_Cooperia_ spp (adult and immature)
_Trichostrongylus_ spp (adult and immature)
_Oesophagostomum_ spp (adult and immature)
_Chabertia_ spp (adult and immature)
LUNGWORMS:
_Dictyocaulusfilaria_ (adult)
TAPEWORMS:
_Moniezia_ spp
SHEEP NASAL FLY:
_Oestrus ovis_ (larvae)
FLUKES:
Chronic and sub-acute fasciolosis due to _Fasciola hepatica_ (mature
and late immature flukes).
4.3 CONTRAINDICATIONS
Do not use in animals with known hypersensitivity to the active
ingredients.
Health Products Regulatory Authority
27 February 2019
CRN008TS7
Page 2 of 5
Do not use in cases where infections with benzimidazole resistant
species are suspected. In this case an appropriate narrow
spectrum product should be used.
The use of this product is contra-indicated in cases of known
hypersensitivity to other benzimadazoles.
(See sections 4.7 and 4.11)
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Care should be taken to avoid the following practices because th